Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb

Platelet activating factor (PAF) is a potent inflammatory lipid. In this study we assessed the ability of PAF to impact lymphatic vessel function by altering prenodal lymphatic resistance. Intralymphatic PAF (7.47 × 10−6, 7.47 × 10−5 and 7.47 × 10−4 M) increased lymphatic perfusion pressure at the t...

Full description

Saved in:
Bibliographic Details
Main Author: D. E. Dobbins
Format: Article
Language:English
Published: Wiley 1992-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/S0962935192000590
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551036999434240
author D. E. Dobbins
author_facet D. E. Dobbins
author_sort D. E. Dobbins
collection DOAJ
description Platelet activating factor (PAF) is a potent inflammatory lipid. In this study we assessed the ability of PAF to impact lymphatic vessel function by altering prenodal lymphatic resistance. Intralymphatic PAF (7.47 × 10−6, 7.47 × 10−5 and 7.47 × 10−4 M) increased lymphatic perfusion pressure at the two highest infusion rates. PAF mediated lymphatic constriction was not altered by the intra-arterial infusion of phentolamine but was blocked by the intra-arterial infusion of the PAF receptor antagonist WEB 2170. These data indicate that in addition to PAF's effects on microvascular permeability, this agent may also impact the ability of the lymphatics to transport fluid through alterations in lymphatic smooth muscle tone. PAF mediated lymphatic constriction is not mediated by α-receptors but rather through PAF receptor mediated mechanism.
format Article
id doaj-art-38a808264a524b94a737017af7f7d50e
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 1992-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-38a808264a524b94a737017af7f7d50e2025-02-03T06:05:07ZengWileyMediators of Inflammation0962-93511466-18611992-01-011639139510.1155/S0962935192000590Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimbD. E. Dobbins0Department of Physiology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USAPlatelet activating factor (PAF) is a potent inflammatory lipid. In this study we assessed the ability of PAF to impact lymphatic vessel function by altering prenodal lymphatic resistance. Intralymphatic PAF (7.47 × 10−6, 7.47 × 10−5 and 7.47 × 10−4 M) increased lymphatic perfusion pressure at the two highest infusion rates. PAF mediated lymphatic constriction was not altered by the intra-arterial infusion of phentolamine but was blocked by the intra-arterial infusion of the PAF receptor antagonist WEB 2170. These data indicate that in addition to PAF's effects on microvascular permeability, this agent may also impact the ability of the lymphatics to transport fluid through alterations in lymphatic smooth muscle tone. PAF mediated lymphatic constriction is not mediated by α-receptors but rather through PAF receptor mediated mechanism.http://dx.doi.org/10.1155/S0962935192000590
spellingShingle D. E. Dobbins
Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
Mediators of Inflammation
title Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
title_full Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
title_fullStr Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
title_full_unstemmed Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
title_short Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
title_sort receptor mechanisms of paf mediated lymphatic constriction in the canine forelimb
url http://dx.doi.org/10.1155/S0962935192000590
work_keys_str_mv AT dedobbins receptormechanismsofpafmediatedlymphaticconstrictioninthecanineforelimb